Abstract
Objective
Psychiatrists are well suited to provide office-based opioid treatment (OBOT), but the extent to which psychiatry residents are exposed to buprenorphine training and OBOT during residency remains unknown.
Methods
Psychiatry residency programs in the USA were recruited to complete a survey.
Results
Forty-one programs were included in the analysis for a response rate of 23.7 %. In total, 75.6 % of the programs currently offered buprenorphine waiver training and 78.1 % provided opportunities to treat opioid dependence with buprenorphine under supervision. Programs generally not only reported favorable beliefs about OBOT and buprenorphine waiver training but also reported numerous barriers.
Conclusions
The majority of psychiatry residency training programs responding to this survey offer buprenorphine waiver training and opportunities to treat opioid-dependent patients, but numerous barriers continue to be cited. More research is needed to understand the role residency training plays in impacting future practice of psychiatrists.
References
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13–4795. Rockville: Substance Abuse and Mental Health Services Administration; 2013.
Birnbaum HG, White AG, Reynolds JL, Greenberg PE, Zhang M, Vallow S, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22(8):667–76.
Clark HW. Office-based practice and opioid-use disorders. N Engl J Med. 2003;349(10):928–30.
Thomas CP, Fullerton CA, Kim M, Montejano L, Lyman DR, Dougherty RH, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv Wash DC. 2014;65(2):158–70.
Hasin D, Kilcoyne B. Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC. Curr Opin Psychiatry. 2012;25(3):165–71.
Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99(1–3):345–9.
Clark W. The state of buprenorphine treatment [Internet]. 2010 [cited 2012 Aug 30]; Buprenorphine in the treatment of opioid addiction: Reassessment 2010. Available from: http://buprenorphine.samhsa.gov/bwns/2010_presentations_pdf/01_Clark_508.pdf
Tesema L, Bergeron G, Yeh J, Soliman M, Hathaway R, Pham C, et al. Auditing access to office-based therapy for opioid addiction in Massachusetts [Internet]. Abstract presented at the 141st American Public Health Association Annual Meeting and Exposition. Boston, MA; 2013. Available from: https://apha.confex.com/apha/141am/webprogram/Paper290933.html
Thomas CP, Reif S, Haq S, Wallack SS, Hoyt A, Ritter GA. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatr Serv Wash DC. 2008;59(8):909–16.
West JC, Kosten TR, Wilk J, Svikis D, Triffleman E, Rae DS, et al. Challenges in increasing access to buprenorphine treatment for opiate addiction. Am J Addict Am Acad Psychiatr Alcohol Addict. 2004;13 Suppl 1:S8–16.
Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014.
Van der Leeuw RM, Lombarts KMJMH, Arah OA, Heineman MJ. A systematic review of the effects of residency training on patient outcomes. BMC Med. 2012;10:65.
Acknowledgments
This study was funded in part by Harvard Medical School Eleanor and Miles Shore Fellowship Program for Scholars in Medicine (JS) and grants U10DA15831 from the National Institute of Drug Abuse (HC).
Disclosures
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suzuki, J., Ellison, T.V., Connery, H.S. et al. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry 40, 498–502 (2016). https://doi.org/10.1007/s40596-015-0313-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40596-015-0313-1